Skip to main content Skip to main navigation menu Skip to site footer
  • Home
  • About
    • About the Journal
    • Aim and Scope
    • Policies
    • Publication Ethics
    • Contact
  • For Authors
    • Author Guidelines
    • Review Guidelines
    • Peer Review Process
    • Article Processing Charges
    • Submissions
  • Articles
    • Current
    • Archives
  • Editorial Board
  • Register
  • Login
Search
  1. Home /
  2. Archives /
  3. Vol. 1 No. 2 (2026): European Journal of Molecular Pharmacy

Vol. 1 No. 2 (2026): European Journal of Molecular Pharmacy

Published: 2026-06-04

Articles

  • Polycystic Ovary Syndrome and the Imperative for Personalized Dosing: Bridging the Gap Between Phenotypic Heterogeneity and Individualized Pharmacotherapy

    Alekhya Ayitha, Merugu Samyuktha, Saka Sai Shree (Author)
    01-14
    • PDF
  • Urinary Free Cortisol Assessment for the Detection of Occult Hypercortisolism in Type 2 Diabetes Mellitus with Difficult-to-Control Hypertension: Clinical Insights from a Prospective Case Series

    Soumik Chatterjee, Soumya Patra (Author)
    15-20
    • PDF
  • Semaglutide as a Renoprotective Metabolic Modulator in Diabetic Nephropathy: An Expanded Case Series from West Bengal, India

    Dr Soumik Chatterjee (Author)
    21-26
    • PDF

License Creative Commons Creative Commons «Attribution» 4.0 WorldWide.


European Journal of Molecular Pharmacy Logo

European Journal of Molecular Pharmacy

A premier peer-reviewed journal for high-impact pharmaceutical research, bridging molecular innovation with clinical discovery.

Flag Counter
Crossref Open Access
Guidelines Publication Ethics Privacy StatementOpen Access Policy
f Instagram

© 2026 The Author(s). This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) .

More information about the publishing system, Platform and Workflow by OJS/PKP.